1. Home
  2. UUUU vs IRON Comparison

UUUU vs IRON Comparison

Compare UUUU & IRON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Energy Fuels Inc (Canada)

UUUU

Energy Fuels Inc (Canada)

N/A

Current Price

$23.01

Market Cap

3.5B

Sector

Industrials

ML Signal

N/A

Logo Disc Medicine Inc.

IRON

Disc Medicine Inc.

N/A

Current Price

$74.71

Market Cap

3.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
UUUU
IRON
Founded
1987
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Mining & Quarrying of Nonmetallic Minerals (No Fuels)
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.0B
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
UUUU
IRON
Price
$23.01
$74.71
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
13
Target Price
$17.00
$108.85
AVG Volume (30 Days)
13.2M
496.6K
Earning Date
02-25-2026
02-26-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$78,742,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$174.53
N/A
P/E Ratio
N/A
N/A
Revenue Growth
103.69
N/A
52 Week Low
$3.20
$30.82
52 Week High
$27.33
$99.50

Technical Indicators

Market Signals
Indicator
UUUU
IRON
Relative Strength Index (RSI) 71.62 39.02
Support Level $20.88 $69.17
Resistance Level $24.35 $75.25
Average True Range (ATR) 1.80 3.21
MACD 0.54 -0.14
Stochastic Oscillator 86.17 42.58

Price Performance

Historical Comparison
UUUU
IRON

About UUUU Energy Fuels Inc (Canada)

Energy Fuels Inc is a United States-based critical minerals company. The Company mines uranium and produces natural uranium concentrates that are sold to nuclear utilities for the production of carbon-free nuclear energy. It holds two of America's key uranium production centers: The White Mesa Mill in Utah, and the Nichols Ranch ISR Facility in Wyoming. It has three reportable segments based on its operations and financial information; Uranium, HMS, and REE.

About IRON Disc Medicine Inc.

Disc Medicine Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for hematologic diseases. It aims to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for erythropoietic porphyrias (EPs) including erythropoietic protoporphyria (EPP), X-linked protoporphyria (XLP), and Diamond-Blackfan Anemia (DBA); DISC-0974 for the treatment of anemia of myelofibrosis (MF) and anemia of chronic kidney disease (CKD); and DISC-3405 for the treatment of polycythemia vera (PV) and other hematologic disorders. In addition, the Company's preclinical programs include DISC-0998.

Share on Social Networks: